共 112 条
[1]
Aguiar D(2005)Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small cell lung cancer Cancer Chemother Pharmacol 55 152-158
[2]
Aguiar J(1998)Salvage treatment with paclitaxel and gemcitabine for patients with non-small cell lung cancer after cisplatin-or docetaxel-based chemotherapy: a multicenter phase II study Ann Oncol 9 1127-1130
[3]
Bohn U(2002)A randomized phase II trial of gemcitabine (G) plus paclitaxel (P) vs gemcitabine plus weekly paclitaxel in the treatment of non-small cell lung cancer (NSCLC) Proc Am Soc Oncol 21 312A-77
[4]
Androulakis N(2002)A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer Lung Cancer 38 73-236
[5]
Kouroussis C(2004)Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatin Lung Cancer 45 227-484
[6]
Kakolyris S(2002)Second-line chemotherapy with irinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer. A phase II study Am J Clin Oncol 25 480-2085
[7]
Tzannes S(1999)Gemcitabine as second-line treatment for advanced non-small cell lung cancer: a phase II trial J Clin Oncol 17 2081-1184
[8]
Papadakis E(2001)Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study Br J Cancer 84 1179-2362
[9]
Papadimitriou C(2000)Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens J Clin Oncol 18 2354-488
[10]
Geroyianni A(2004)Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomized, phase II study Br J Cancer 91 482-138